SMYD3 links lysine methylation of MAP3K2 to ras-driven lung cancer

Nicolas Reynoird (La Tronche, France), Nicolas Reynoird, Pawel Mazur, Julien Sage, Or Gozani

Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers
Session: Cell biology of lung cancer and new biomarkers
Session type: Thematic Poster Session
Number: 4256
Disease area: Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Nicolas Reynoird (La Tronche, France), Nicolas Reynoird, Pawel Mazur, Julien Sage, Or Gozani. SMYD3 links lysine methylation of MAP3K2 to ras-driven lung cancer. Eur Respir J 2015; 46: Suppl. 59, 4256

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Hypermethylation of RASSF1A, CDH13 and DAPK gene play a role in NSCLC pathogenesis
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013

Methylation associated pathway activity deregulation in lung adenocarcinoma
Source: International Congress 2014 – Novel approaches in transcriptomics and epigenomics in inflammatory lung diseases and lung cancer
Year: 2014



DNA methylation profiling of non-small cell lung cancer reveals an immune signature in COPD patients
Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome)
Year: 2013


Significance of EGFR expression patterns in patients with non-small cell lung cancer – Evaluation on protein- and/or gene level?
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014


Expression analysis of miR-21 in Bulgarian patients with non-small cell lung cancer
Source: International Congress 2016 – Prognostic variables in lung cancer I
Year: 2016


Proapoptotic effects of PAI-1 protein on lung and prostate cancer cells
Source: Annual Congress 2013 –Basic research on lung cancer
Year: 2013


Correlation of miR-422a, miR-21 and miR-155 analysis with hMSH2 and hMLH1 mRNA expression profiles in non-small cell lung carcinomas and their adjacent normal tissues
Source: Annual Congress 2013 –Biology and molecular pathology of lung cancer
Year: 2013

The methylation profiling of multiple tumor suppressor genes in plasma cell-free DNA from patients with NSCLC versus non-malignant tumors - pilot study
Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases
Year: 2014

Expression of the ILK-PINCH-PARVIN (IPP) complex and its binding partner Rsu-1 in human non-small cell lung cancer
Source: International Congress 2016 – Prognostic variables in lung cancer II
Year: 2016

Prognostic value of survivin gene promoter polymorphisms in non-small cell lung cancer
Source: International Congress 2016 – Prognostic variables in lung cancer I
Year: 2016

Telomere-associated gene network in lung adenocarcinoma
Source: International Congress 2015 – Respiratory translational research: novel mechanisms, diagnostic markers and Space Odyssey
Year: 2015



Role of hypoxia in epithelial-to-mesenchymal transition (EMT) in non-small cell lung cancer (NSCLC)
Source: International Congress 2014 – Basic and translational research in lung cancer and non-neoplastic pulmonary diseases
Year: 2014

Translocation of beta-catenin into cytoplasm during TGFbeta-induced EMT is negatively regulated by phosphorylation of the PTEN C-terminus in lung cancers
Source: Annual Congress 2013 –Novel in vitro and animal models to study lung diseases
Year: 2013


Gene expression of EGFR, MINA53,MEN1 and MTOR in NSCLCs
Source: International Congress 2014 – Biology and pathology of thoracic tumours
Year: 2014


Prognostic value and functional characterization of miR-141 and miR-200c expression levels in resected NSCL
Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours
Year: 2014


Micro-RNA screening in neuroendocrine lung tumors: Differential expression of miR-29 family members
Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome)
Year: 2013



Epigenetic alterations in the circulating DNA from blood of patients with COPD and lung cancer
Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making
Year: 2013

Methylation of p16 in EBUS-TBNA samples as a predictor of advanced disease in lung cancer
Source: Annual Congress 2013 –Genetics and genomics of lung disease
Year: 2013

The role of HIF-1 pathway in non-small-cell lung cancer
Source: International Congress 2016 – Prognostic variables in lung cancer I
Year: 2016

Histone demethylation and acetylation are involved in the epigenetic regulation of epithelial-mesenchymal transition (EMT)
Source: Annual Congress 2013 –Novel mechanisms in lung injury
Year: 2013